Trends in HIV / AIDS mortality in the city of Pereira, Colombia (2002-2014): ecological study
DOI:
https://doi.org/10.17533/udea.iatreia.35Keywords:
cause of death, Colombia, mortality, AIDS serodiagnosis, acquired immunodeficiency syndromeAbstract
Objective: To evaluate trends in HIV mortality and its associated factors in the period 2002-2014 for the municipality of Pereira.
Materials and methods: Ecological study, using as a source of information the databases of death certificates codified by the National Administrative Department of Statistics. The variables selected to estimate the trends were: age, sex, area of residence and cause of death. An exploratory analysis was carried out applying descriptive statistics for the calculation of percentages, measures of central tendency and variability. Joinpoint regression was applied to identify trends in adjusted rates.
Results: The average mortality of patients with HIV infection in the period 2002-2014 was 11.9 per 100,000 people. Mortality remained stable without presenting statistically significant variations in the evaluated period (VPAP: 2.6, 95% CI: -2.7 -8.1, p = 0.6), with an increase of 14.3% per year from 2002 to the year 2005 and another tendency to decrease by -1.1% per year in the period 2005-2014. Mortality was greater in males, elderly patients, those with non-infectious diseases and residing in urban areas.
Conclusion: There was a high mortality of patients with HIV infection and a trend without significant variations in the period of the years 2002-2014 in the city of Pereira, Colombia.
Downloads
References
(1.) Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS. 2013;27(13):2003-17. DOI 10.1097/QAD.0b013e328362ba67.
(2.) Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. NEJM. 1998;338(13):853-60. DOI 10.1056/NEJM199803263381301.
(3.) Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119-29. DOI 10.1016/S0140-6736(02)09411-4.
(4.) Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663-71. DOI 10.1097/00002030-200208160-00012.
(5.) Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135(1):17-26. DOI 10.7326/0003-4819-135-1-200107030-00005.
(6.) UNAIDS. Unaids data 2017 [internet]. [Consultado 2019 mar 05]. Disponible en: http://cort.as/-L4Jf
(7.) Dubé K, Luter S, Lesnar B, Newton L, Galea J, Brown B, et al. Use of ‘eradication’ in HIV cure-related research: a public health debate. BMC public health. 2018;18(1):245. DOI 10.1186/s12889-018-5141-2.
(8.) Cataño JC, HIV in Colombia: an Epidemiologic Point of View. Curr Trop Med Rep. 2018;5(2):77-84. DOI 10.1007/s40475-018-0141-y.
(9.) Cuenta de Alto Costo. Situación Actual del VIH en Colombia, 2017 [internet]. [Consultado 2019 feb 20]. Disponible en: http://cort.as/-L4Lf
(10.) Saldarriaga-Arenas PA, Rodríguez-Morales AJ. Tendencias epidemiológicas en el comportamiento de la infección por VIH/SIDA en el municipio Pereira, Colombia, 1998-2011. Rev Med Ris. 2012;18:140-4.
(11.) Yu B, Huang L, Tiwari RC, Feuer EJ, Johnson KA. Modelling population-based cancer survival trends using join point models for grouped survival data. J R Stat Soc Ser A Stat Soc. 2009;172(2):405-25. DOI 10.1111/j.1467-985X.2009.00580.x.
(12.) Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51. DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AIDSIM336>3.0.CO;2-Z.
(13.) Colombia. Ministerio de Salud y Portección Soccial. Análisis De Situación De Salud (ASIS), Colombia 2017. Bogotá: El Ministerio;2018.
(14.) Chen L, Pan X, Ma Q, Yang J, Xu Y, Zheng J, et al. HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006-2013. Sci Rep. 2017;7:42366. DOI 10.1038/srep42366.
(15.) Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health. 2017;2(1):e35-e46. DOI 10.1016/S2468-2667(16)30020-2.
(16.) Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, Shaukat M, et al. Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India. PloS One. 2013;8(6):e66860. DOI 10.1371/journal.pone.0066860.
(17.) Machado-Alba JE, Gonzalez-Santos DM, Vidal-Guitart X. Effectiveness of antiretroviral treatment in patients from Pereira and Manizales. Rev Salud Publica (Bogota). 2011;13(3):492-503.
(18.) Arrivillaga M, Ross M, Useche B, Alzate ML, Correa D. Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Rev Panam Salud Publica. 2009;26(6):502-10. DOI 10.1590/s1020-49892009001200005.
(19.) Varela Arévalo MT, Gómez Gutiérrez OL, Mueses Marían HF, Quintero JG, Tello Bolívar IC. Factores relacionados con la adherencia al tratamiento farmacológico para el VIH/SIDA. Salud Uninorte. 2013;29(1):83-95.
(20.) Krentz HB, MacDonald J, John Gill M. High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care? Open Forum Infect Dis. 2014;1(1). DOI 10.1093/ofid/ofu011.
(21.) Seyoum D, Degryse JM, Kifle YG, Taye A, Tadesse M, Birlie B, et al. Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models. Int J Environ Res Public Health. 2017;14(3):296. DOI 10.3390/ijerph14030296.
(22.) Gunda DW, Nkandala I, Kilonzo SB, Kilangi BB, Mpondo BC. Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study. J Sex Transm Dis. 2017;2017:8. DOI 10.1155/2017/7075601.
(23.) Garriga C, Garcia de Olalla P, Miro JM, Ocana I, Knobel H, Barbera MJ, et al. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort. PloS one. 2015;10(12):e0145701. DOI 10.1371/journal.pone.0145701.
(24.) Coelho L, Grinsztejn B, Castilho JL, De Boni R, Quintana MSB, Campos DP, et al. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. Lancet HIV. 2016;3(10):e490-e8. DOI 10.1016/S2352-3018(16)30052-2.
(25.) Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt). 2008;17(1):47-55. DOI 10.1089/jwh.2007.0353.
(26.) Grinsztejn B, Luz PM, Pacheco AG, Santos DV, Velasque L, Moreira RI, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PloS One. 2013;8(4):e59768. DOI 10.1371/journal.pone.0059768.
(27.) Mpondo BCT. HIV Infection in the Elderly: Arising Challenges. J Aging Res. 2016;2016:2404857. DOI 10.1155/2016/2404857.
(28.) Mack KA, Ory MG. AIDS and older Americans at the end of the Twentieth Century. J Acquir Immune Defic Syndr. 2003;33. DOI 10.1097/00126334-200306012-00003.
(29.) Zablotsky D, Kennedy M. Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practices. J Acquir Immune Defic Syndr. 2003;33. DOI 10.1097/00126334-200306012-00009.
(30.) Rubaihayo J, Tumwesigye NM, Konde-Lule J, Makumbi F, Nakku EJ, Wamani H, et al. Trends and Predictors of Mortality Among HIV Positive Patients in the Era of Highly Active Antiretroviral Therapy in Uganda. Infect Dis Rep. 2015;7(3):5967. DOI 10.4081/idr.2015.5967.
(31.) Semeere AS, Lwanga I, Sempa J, Parikh S, Nakasujja N, Cumming R, et al. Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda. J Acquir Immune Defic Syndr. 2014;67(4):382-9. DOI 10.1097/QAI.0000000000000330.
(32.) Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590-8. DOI 10.1097/QAI.0b013e31817efb54.
(33.) Machado JE, Martínez JW. Asociación tuberculosis y VIH en pacientes de Pereira, Colombia. Colomb. méd. 2005;36(4).
(34.) Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871-a. DOI 10.1101/cshperspect.a017871.
(35.) Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infection in HIV-infected Indian patients. AIDS Patient Care STDS. 2004;18(4):209-13. DOI 10.1089/108729104323038883.
(36.) García I, Merchán A, Chaparro PE, López LE. Panorama de la coinfección tuberculosis/VIH en Bogotá, 2001. Biomédica. 2004;24:132-7.
(37.) Aerts D, Jobim R. The epidemiological profile of tuberculosis in southern Brazil in times of AIDS. Int J Tuberc Lung Dis. 2004;8(6):785-91.
(38.) Trepka MJ, Fennie KP, Sheehan DM, Lutfi K, Maddox L, Lieb S. Late HIV diagnosis: Differences by rural/urban residence, Florida, 2007-2011. AIDS Patient Care STDS. 2014;28(4):188-97. DOI 10.1089/apc.2013.0362.
(39.) Lewis DK, Callaghan M, Phiri K, Chipwete J, Kublin JG, Borgstein E, et al. Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi. J Trop Med Hyg. 2003;97(1):91-6. DOI 10.1016/s0035-9203(03)90035-6.
(40.) Keith Branham D, Borders TF, Stewart KE, Curran GM, Booth BM. Acceptability of HIV Testing Sites Among Rural and Urban African Americans Who Use Cocaine. AIDS Behav. 2017;21(2):576-86. DOI 10.1007/s10461-016-1527-2.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
